Concept explainers
Several compounds have been found to inhibit β-lactamase, and drugs based on these compounds can be taken in combination with penicillins and cephalosporins to restore their effectiveness when resistance is known to be a problem. The commonly prescribed formulation called Augmentin is a combination of the β-lactamase inhibitor shown below with amoxicillin (shown above). It is used to treat childhood ear infections when resistance is suspected, and many kids know it as the white liquid that tastes like bananas. Which of the statements below are true statements?
- 1. The stereochemistry of the fusion between the four-and five-membered rings in the inhibitor and amoxicillin are different.
- 2. The inhibitor possesses enol ether and allylic alcohol
functional groups while the antibiotic possesses a phenol and a secondary amide functional group. - 3. Neither the inhibitor nor the antibiotic contains strained rings.
- 4. Both 1 and 2 are true.
![Check Mark](/static/check-mark.png)
Want to see the full answer?
Check out a sample textbook solution![Blurred answer](/static/blurred-answer.jpg)
Chapter 18 Solutions
EP ORGANIC CHEMISTRY-OWL V2 ACCESS
Additional Science Textbook Solutions
Living By Chemistry: First Edition Textbook
Basic Chemistry (5th Edition)
Organic Chemistry (8th Edition)
Chemistry: Atoms First
Fundamentals of Heat and Mass Transfer
- Explain the following terms with one suitable example for each: (i) A sweetening agent for diabetic person (ii) Enzymes (iii) Analgesicsarrow_forwardExplain the following terms with one suitable example for each :(i) A sweetening agent for diabetic patients(ii) Enzymes(iii) Analgesicsarrow_forwardWhich is true about the ß-lactam compounds? their pharmacophore has five-membered ring structure they work only on Gram-negative bacteria O they work as inhibitor in cell membrane synthesis O they are irreversible inhibitors of the bacterial serine proteasearrow_forward
- 1. Biogenic Amines are inactivated primarily by a. Sulfonation b. Glucoronidation c. Aromatic hydroxylation d. Methylation 2. A drug can exert its pharmacological effect only if it is a. Protein bound b. Protein unbound c. Free drug d. Both B & C e. Both A & C 3. In order for the drug to be ready and available for absorption, it must be release first from its dosage form with the exception of: a. Capsule b. Tablet c. Solution d. Suspension 4. All of the following are true, except a. Solubility increase with decrease particle size b. Solubility increase with increase surface area c. Solubility increase with increase particle size d. Solubility decrease with decrease surface area 5. The rate in which the drug appears in the bloodstream is also known as a. Half-life b. Potency c. Bioavailability d. Area under the curvearrow_forward1. The antibacterial activity of flavonoids was tested against the bacterial strain, Escherichia coli. The minimum inhibitory concentration at which 50% of the compounds were inhibited (MIC50) are presented in the table below for some of the compounds. Table 1: Antibacterial activity of flavonoids tested against E. coli Compound Kaempferol Quercetin Compound X Luteolin Tangeritin 5,6,7,4'- Tetramethoxyflavone Genistin Genistein MIC50 (µg/mL) 25.50 35.76 36.72 67.25 137.10 156.34 238.94 320.88 1.3 Would myricetin have higher or lower antibacterial activity compared to quercetin? Justify your answer by using the results provided.arrow_forward1. The antibacterial activity of flavonoids was tested against the bacterial strain, Escherichia coli. The minimum inhibitory concentration at which 50% of the compounds were inhibited (MIC50) are presented in the table below for some of the compounds. Table 1: Antibacterial activity of flavonoids tested against E. coli Compound Kaempferol Quercetin Compound X Luteolin Tangeritin 5,6,7,4'- Tetramethoxyflavone Genistin Genistein MIC50 (μg/mL) 25.50 35.76 36.72 67.25 137.10 156.34 238.94 320.88 1.1 What subgroups of flavonoids do these belong to.arrow_forward
- Dipalmitoylphosphatidylcholine is a surfactant found in the lining of the lungs. It prevents the lungs from collapsing when the lung volume is low and protects the lungs from injuries caused by inhaled particles. Draw its structure.arrow_forward4arrow_forwardNeostigmine is an inhibitor of acetylcholinesterase. The enzyme attempts to catalyse the same reaction on neostigmine as it does with acetylcholine. However, a stable intermediate is formed which prevents completion of the process and which results in a molecule being covalently linked to the active site. Identify (draw) the stable intermediate and explain why it is stable.arrow_forward
- 1. What is the role of initiator and inhibitor? 2. What are short stops?arrow_forwardWhat causes deficiency of norepinephrine and what happens when norepinephrine levels are low? 2. What is the difference between norepinephrine and epinephrine in terms of structure?arrow_forwardBenzodiazepines are known to have a wide therapeutic window. What makes benzodiazepines relatively safe even when consumed in higher than therapeutic doses?arrow_forward
- Organic ChemistryChemistryISBN:9781305580350Author:William H. Brown, Brent L. Iverson, Eric Anslyn, Christopher S. FootePublisher:Cengage LearningIntroduction to General, Organic and BiochemistryChemistryISBN:9781285869759Author:Frederick A. Bettelheim, William H. Brown, Mary K. Campbell, Shawn O. Farrell, Omar TorresPublisher:Cengage LearningGeneral, Organic, and Biological ChemistryChemistryISBN:9781285853918Author:H. Stephen StokerPublisher:Cengage Learning
- Organic And Biological ChemistryChemistryISBN:9781305081079Author:STOKER, H. Stephen (howard Stephen)Publisher:Cengage Learning,Chemistry for Today: General, Organic, and Bioche...ChemistryISBN:9781305960060Author:Spencer L. Seager, Michael R. Slabaugh, Maren S. HansenPublisher:Cengage Learning
![Text book image](https://www.bartleby.com/isbn_cover_images/9781305580350/9781305580350_smallCoverImage.gif)
![Text book image](https://www.bartleby.com/isbn_cover_images/9781285869759/9781285869759_smallCoverImage.gif)
![Text book image](https://www.bartleby.com/isbn_cover_images/9781285853918/9781285853918_smallCoverImage.gif)
![Text book image](https://www.bartleby.com/isbn_cover_images/9781305081079/9781305081079_smallCoverImage.gif)
![Text book image](https://www.bartleby.com/isbn_cover_images/9781305960060/9781305960060_smallCoverImage.gif)
![Text book image](https://www.bartleby.com/isbn_cover_images/9781305080485/9781305080485_smallCoverImage.gif)